Abstract
ABSTRACTObjectiveProliferating cancer cells shift their metabolism to anaerobic glycolysis even in the presence of oxygen to generate glycolytic intermediates as substrates for anabolic reactions. We hypothesise that a similar metabolic remodelling also occurs during physiological skeletal muscle hypertrophy.MethodsWe used mass spectrometry in hypertrophying muscles both in C2C12 muscle cellsin vitroand plantaris mice musclein vivoand assessed metabolomic changes and the incorporation of stable isotope [U-13C6]glucose tracer compared with non-treated controls. We also performed enzyme inhibition for further mechanistic analysis and a systematic review to align any changes in metabolomics during muscle growth with previous findings.ResultsBoth our metabolomics analysis and the systematic review reveal altered metabolite concentrations in anabolic pathways such as in the pentose phosphate and serine synthesis pathway to build up biomass, as well as in the hexosamine biosynthetic pathway that serves as a basis for the post-translational so-calledO-linked glycosylation modification. We further demonstrated that labelled carbon from [U-13C6]glucose is increasingly incorporated into the non-essential amino acids in hypertrophying myotubes. The inhibition of the key enzyme phosphoglycerate dehydrogenase (Phgdh) supresses muscle protein synthesis by 75% highlighting the importance of the serine pathway for maintaining muscle size.ConclusionUnderstanding the mechanisms that regulates skeletal muscle mass will help in developing effective treatments against muscle weakness. Our results provide evidence for metabolic rewiring of glycolytic intermediates into anabolic pathways during muscle growth, such as in the serine synthesis and hexosamine biosynthetic pathways.
Publisher
Cold Spring Harbor Laboratory
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献